Gwen Bame, former Covidien exec, joins InspireMD upper management
Israel-based InspireMD (OTC:NSPR) hired Gwen Bame as vice president of corporate affairs.
Bame joins the device company from Covidien (NYSE:COV), where she held executive level marketing positions. Formerly, she worked in cardiology sales at Boston Scientific (NYSE:BSX), where she negotiated roughly $350 million in contracted business.
New CEO at Noridian
Noridian, the Fargo, N.D.-based insurance claims contractor, named Tom McGraw as the company’s 2nd CEO. McGraw joined Noridian from Amerigroup Corp., where he worked as senior VP of business development.
He’s also logged upper management experience at OptumInsight and Maximus Inc.
Accuray promotes 2 from within
Accuray (NSDQ:ARAY) promoted Kelly Londy to executive VP & CCO, and promoted Robert Ragusa to executive VP of engineering & global operations. Both employees get a salary bump to $350,000 per year and renewed stock options, according to company SEC filings.
Orchid appoints orthopedic surgeon as medical director of cost containment
Orchid Medical named William Kennedy of the Kennedy-White Orthopedic Center in Sarasota, Fla., as the company’s medical director of the surgical cost containment program.
Orchid launched the cost containment program in 2011, aimed at curbing over-use of implantable devices and cost savings in workers’ compensation.
Kennedy has over 30 years experience as an orthopedic surgeon.
New board member at Medtronic
The board of directors at Medtronic (NYSE:MDT) elected Scott Donnelly as an independent director, effective July 1, 2013. Donnelly is the CEO of Textron, a position he has held since 2009. Donnelly also formerly worked in several executive roles at GE (NYSE:GE) from 1989 to 2008.